The regulatory file for L-carnitine tartrate
L-carnitine is an established food ingredient in the European Union and a dietary ingredient in the United States; the tartrate is a salt form with its own specification, safety evaluation and label name. Permission is only the first question. The destination's level rule, the label wording and the contaminant calculation sit in the same file, and the buyer's regulatory team confirms them.
The tartrate is a carnitine salt with an established food history, but the form, the national level rule and the label wording are separate questions that the destination decides.
What the file has to hold
One certificate can be enough for one market and incomplete for another. The file for L-carnitine tartrate holds the specification version, the lot certificate, the destination's permission and dose rule, the label review and the change-control record for source, process and pack. The certificate supports the material; it does not settle the route.
Keep the documents in one versioned list: specification, COA, TDS, SDS, allergen and GMO statements, origin record, food-contact declaration for the pouch or liner, and the market statement the importer needs. A missing line is easier to close at quotation than at the port.
European Union
L-carnitine has a documented history of use in food supplements before 15 May 1997 and is not treated as a novel food as of this review. The tartrate is a salt form of that substance, and EFSA evaluated L-carnitine-L-tartrate as a carnitine source for foods for particular nutritional uses in 2003. That evaluation supports the use; it is not a food-supplement maximum.
Food supplements fall under Directive 2002/46/EC, and carnitine is not one of the harmonised vitamins and minerals, so a member state may set a maximum level, require a notification or restrict a form. There is no single EU-wide dose answer. Check the current national rule for each destination as of this review, and record the source of the rule in the file.
United States
L-carnitine was marketed as a dietary ingredient before 15 October 1994 and is not a new dietary ingredient as of this review. L-carnitine L-tartrate is used as a carnitine source, and GRAS conclusions exist for specific uses such as infant formula; a GRAS conclusion for one use is not a permission for every food.
For a supplement, the manufacturing rules sit in 21 CFR 111 and the panel format in 21 CFR 101.36. The carnitine figure is declared per serving without a Daily Value percentage, because no Daily Value has been set for it. A structure or function statement is allowed with substantiation and the DSHEA disclaimer; a disease statement is not.
United Kingdom
Great Britain applies retained food law and its own novel-food register; Northern Ireland follows the EU framework under the Windsor Framework. The delivery address decides which file applies, so the buyer's regulatory team should record that decision with the order. A GB-only review is not a substitute for the EU position, and the reverse is also true.
Contaminants and the finished-product calculation
The heavy-metal lines are specification terms, and some of them sit at the legal maximum for a food supplement. Coincidence is not margin: a limit at the legal line leaves nothing for analytical uncertainty.
| Parameter | Catalog limit | EU legal position, as of this review |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | 3.0 mg/kg maximum; the catalog sits at the line |
| Cadmium (Cd) | ≤1 mg/kg | 1.0 mg/kg maximum; the catalog sits at the line |
| Mercury (Hg) | ≤0.1 mg/kg | 0.10 mg/kg maximum; the catalog sits at the line |
| Arsenic (As) | ≤2 mg/kg | No harmonised EU maximum; the line is contractual |
| Microbiology | Counts and absence tests | Process hygiene and the buyer's specification |
The calculation is per daily dose, not per kilogram of powder. A lot that passes the drum limit can still exceed the finished-product limit if the serving is large, and the file should show the conversion. In the US, California's Proposition 65 adds a warning threshold for lead and cadmium assessed per dose, so a lot can satisfy the specification and still raise a label question in one state.
Claims and the edge of the label
On the EU side, Regulation 1924/2006 requires an authorised entry before a health claim can appear on the label, and the register is the place to check it. As of this review there is no authorised claim for L-carnitine, so any health wording needs a citation that can be produced. A compositional line such as “L-carnitine L-tartrate 500 mg per capsule” is not a health claim; it still has to agree with the specification and with the basis of the figure.
In the US, the structure or function route is open with the disclaimer, but it rests on substantiation held by the brand owner and does not extend to a disease. This site publishes the specification and makes no health claim; the claim decision belongs to the brand with the market's rules in front of it.
Documents for the tartrate file
- A lot certificate naming the form, the salt assay, the carnitine content and the basis.
- The versioned specification with the mesh, the pack and the storage condition.
- The safety data sheet and an allergen statement covering the material and the pack.
- A manufacturing site and country-of-origin statement naming the actual producer.
- An EU statement showing the pre-1997 history, and the tartrate evaluation where the use relies on it.
- A US dietary ingredient statement, or the GRAS basis for the intended use.
- The food-contact statement for the pouch or liner, written for the destination.
- The stability summary and the shelf life written for the actual pack, not for a different container.
The COA and the specification are the core. The rest of the file answers questions the certificate cannot: where the lot was made, what the pack is, and which market route the buyer intends. A document set that is complete for a supplement may not cover a conventional food, and a beverage dossier is a separate filing.
A short review checklist
- The form is written the same way on the specification, the certificate and the label.
- The level rule has been checked for the destination rather than borrowed from another market.
- The carnitine figure and the salt figure are both stated, with the basis.
- The contaminant results are converted to the finished-product dose.
- The label and any claim have been reviewed for the destination.
- The pack and the storage condition are in the specification.
- A change of form, source or site triggers a new specification and a new review.
The product page carries the catalog specification; the L-carnitine page covers the base form; the methods index describes the assays; the quality page describes the release file; and the EU regulatory notes collect the framework references.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation